ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure

THURSDAY, June 4, 2026-- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposure is associated with a lower incidence of breast cancer, according to a study published online June 2 in JCO Oncology Practice to coincide with the annual meeting...